THE Overall Objective of This Contract IS to Advance the Development of the Frontlineodp(tm) System for Producing a Point of Care Plasma Product for Transfusion. the Scope IS Defined in the SOW Below
Contract Overview
Contract Amount: $135,607,236 ($135.6M)
Contractor: Velico Medical, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2021-08-02
End Date: 2029-11-30
Official Description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE FRONTLINEODP(TM) SYSTEM FOR PRODUCING A POINT OF CARE PLASMA PRODUCT FOR TRANSFUSION. THE SCOPE IS DEFINED IN THE SOW BELOW.